Substratum of Proof LGBTQs Are Mentally Ill: NIH and partners launch HIV vaccine efficacy study

(NIH/National Institute of Allergy and Infectious Diseases) The National Institutes of Health and partners have launched a large clinical trial to assess whether an experimental HIV vaccine regimen is safe and able to prevent HIV infection. The new Phase 2b proof-of-concept study, called Imbokodo, aims to enroll 2,600 HIV-negative women in sub-Saharan Africa. Of 1.8 million new HIV infections worldwide in 2016, 43 percent occurred in eastern and southern Africa, with women and girls disproportio…